A Col­orado biotech ends clin­i­cal work to fo­cus on mar­ket­ing AD­HD drug, con­sumer health prod­ucts

A bio­phar­ma that mar­kets an AD­HD med­ica­tion, and sells a port­fo­lio of over-the-counter con­sumer health prod­ucts on Ama­zon and else­where, has de­cid­ed to scrap all …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER